Product

CoV2-OGEN1

1 clinical trial

1 indication

Indication
COVID-19
Clinical trial
First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects
Status: Completed, Estimated PCD: 2022-11-11